Effect of acute and chronic glucocorticoid therapy on insulin sensitivity and postprandial vascular function
- 23 October 2015
- journal article
- clinical trial
- Published by Wiley in Clinical Endocrinology
- Vol. 84 (4) , 501-508
Abstract
Summary: Objective: Postprandial hyperglycaemia is associated with increased arterial stiffness and cardiovascular events. Low‐dose prednisolone causes insulin resistance that typically manifests as postprandial hyperglycaemia. We investigated whether prednisolone causes postprandial vascular dysfunction in a cohort of patients with rheumatoid arthritis.Design: An open interventional and cross‐sectional study was undertaken.Patients and measurements: Eighteen subjects with rheumatoid arthritis who had not taken oral glucocorticoids for ≥6 months were studied before and after prednisolone 6 mg/day for 7 days to determine the acute effects of prednisolone. Pre‐prednisolone data were compared to 18 subjects with rheumatoid arthritis taking long‐term (>6 months) prednisolone (6·5 ± 1·8 mg/day) to assess the chronic effects of prednisolone. Augmentation index (by applanation tonometry) and reactive hyperaemia index (by peripheral artery tonometry) were measured before and after a mixed‐meal (10 kcal/kg, 45% carbohydrate, 15% protein, 40% fat). Insulin sensitivity was estimated by the Matsuda index and sympathetic nervous system activity from urinary noradrenaline excretion.Results: Matsuda index was lower after acute (2·0 ± 1·0 vs 3·6 ± 1·1, P = 0·01) and chronic (1·9 ± 1·0 vs 3·6 ± 1·1, P = 0·04) prednisolone. Postprandial augmentation index was lower after acute prednisolone (2551 ± 197 vs 2690 ± 272%*min, P ≤ 0·001), but not chronic prednisolone. There were no significant differences in reactive hyperaemia index with acute or chronic prednisolone. Noradrenaline excretion was lower after acute (54 ± 8 vs 93 ± 23 nmol/6 h, P = 0·02), but not chronic, prednisolone.Conclusions: Prednisolone‐induced insulin resistance is not associated with postprandial vascular dysfunction in patients with rheumatoid arthritis. Reduced sympathetic activity may contribute to the reduction in postprandial arterial stiffness with acute prednisolone.Keywords
Funding Information
- Diabetes Australia Research Trust (Y12G BURM)
This publication has 33 references indexed in Scilit:
- Acute effect of calcium citrate on serum calcium and cardiovascular functionJournal of Bone and Mineral Research, 2012
- Glucagon-Like Peptide-1 Receptor Agonist Treatment Prevents Glucocorticoid-Induced Glucose Intolerance and Islet-Cell Dysfunction in HumansDiabetes Care, 2011
- Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009Diabetologia, 2010
- Post-Challenge Hyperglycemia in Older Adults Is Associated with Increased Cardiovascular Risk ProfileThe Journal of Clinical Endocrinology & Metabolism, 2009
- Nongenomic Glucocorticoid Effects on Activity-Dependent Potentiation of Catecholamine Release in Chromaffin CellsEndocrinology, 2008
- Microvascular DysfunctionHypertension, 2007
- Effect of postprandial insulinemia and insulin resistance on measurement of arterial stiffness (augmentation index)International Journal of Cardiology, 2007
- Effect of anti-TNFα treatment on circulating endothelial progenitor cells (EPCs) in rheumatoid arthritisLife Sciences, 2006
- Expert consensus document on arterial stiffness: methodological issues and clinical applicationsEuropean Heart Journal, 2006
- Low‐dose prednisolone in addition to the initial disease‐modifying antirheumatic drug in patients with early active rheumatoid arthritis reduces joint destruction and increases the remission rate: A two‐year randomized trialArthritis & Rheumatism, 2005